Zacks.com releases the latest Analyst Interview. Today’s interview is with senior analyst Chris Kallos, who discusses WellPoint (NYSE: WLP), Humana (NYSE: HUM) and Healthsouth (NYSE: HLS).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=2678.
What would be your top Buy recommendation at the current time?
Despite our currently neutral stance on managed care providers overall, we continue to rate WellPoint (NYSE: WLP) as a Buy given its broad product offering, geographic reach, and potential for added synergy gains from relatively recent acquisitions. Furthermore managed care companies in general remain well-capitalized and unlikely to be affected by the current credit crisis, negative investor sentiment aside.
Humana (NYSE: HUM) also remains attractive at current levels. The company is one of the nation’s largest healthcare plan providers in the United States, with approval from The Centers for Medicare & Medicaid Services (CMS) to offer the Medicare Part D prescription drug plan (PDP) to the more than 42 million Medicare eligible beneficiaries.
Any Sell recommendations worth noting?
Highly leveraged companies are obviously more likely to be affected by any deterioration of the current credit crisis. For example, Healthsouth (NYSE: HLS), which, despite efforts to reduce debt exposure, remains vulnerable.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks Profit from the Pros e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2679.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4581.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts:
Mark Vickery
Zacks Web Content Editor
312-265-9380
Visit:
www.zacks.com
